CIK 0001420720 · Non-accelerated filer<br>Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262797813
- Phone
- 302 355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- 8-K Event Material agreement · Acquisition or sale completed · Regulation FD disclosure
- 8-K Event Auditor change
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · New debt or obligation
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- 8-K Event Unregistered share sale · Other events
- 8-K Event Material agreement · Other events
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 8-K Event Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
- UPLOAD Other SEC-generated Letter
Page 11 of 46 · 911 filings